Braidwell LP Amgen Inc Transaction History

Braidwell LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $5.63 Million - $6.35 Million	22,000 Added 60.77%	58,200 $16.8 Billion
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $7.92 Million - $9.83 Million	36,200 New	36,200 $9.73 Billion
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $6.86 Million - $8.37 Million	30,400 Added 23.19%	161,500 $39 Billion
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $30 Million - $38.2 Million	131,100 New	131,100 $34.4 Billion

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.